Variants of the Angiogenic Factor Vascular Endothelial Cell Growth Factor: VEGF

Details for Australian Patent Application No. 2004200697 (hide)

Owner Collateral Therapeutics, Inc.

Inventors Andreason, Grai; Baird, Andrew

Agent Spruson & Ferguson

Pub. Number AU-A-2004200697

Parent 767662

Filing date 20 February 2004

Wipo publication date 18 March 2004

International Classifications

C12N 015/19 Mutation or genetic engineering - Interferons

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 038/19 Medicinal preparations containing peptides - Cytokines

C12N 015/86 Mutation or genetic engineering - Viral vectors

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C07K 014/52 Peptides having more than 20 amino acids

Event Publications

4 March 2004 Complete Application Filed

18 March 2004 Application Open to Public Inspection

  Published as AU-A-2004200697

21 September 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004200698-Process for Treating Gold Ores with Stibnite

2004200696-The improvement of vehicle shock absorber